MyMedR

Displaying all 10 publications

Abstract:

Sort:

Renal glycosuria

Kew-kim C

Med J Malaya, 1969 Jun;23(4):256-9.
PMID: 4242171
CHORIOCARCINOMA

KIM CK

Med J Malaysia, 1964 Dec;19:140-4.
PMID: 14279237
Sickle-cell anaemia in an Indian family in Johore

Kim CK, Durham NA

Med J Malaya, 1965 Mar;19(3):172-83.
PMID: 4220469
New species of Itara (Orthoptera: Grylloidea: Itarinae) and descriptions of calling songs from Mindanao and Sabah

Tan MK, Grumo KC, Gono AIA, Bahoy DCM, Rivera RR, Nueza OM, et al.

Zootaxa, 2024 Mar 12;5424(1):61-79.
PMID: 38480300 DOI: 10.11646/zootaxa.5424.1.3

A new species of Itara (Phormincter) is described from Mindanao in the Philippines: Itara (Phormincter) mindanao Tan, Grumo, Gono & Bahoy, sp. nov. This represents the first record of this subgenus in the Philippines, having previously known only from Borneo, Java, Malay Peninsula and Sumatra; as well as only the second species of Itara known from the Philippines and the first from Mindanao Island. The male calling song of the holotype was also recorded and is described here. Additionally, the male calling song of another congener, Itara (Singitara) singularis Gorochov, 1997 from Sabah, is described here. A new species of Itara (Bornitara) is also described from Sabah in Borneo: Itara (Bornitara) tenompok Tan, Japir & Chung, sp. nov.
Fulltext Author Correction: The Plasmodium falciparum male gametocyte protein P230p, a paralog of P230, is vital for ookinete formation and mosquito transmission

Marin-Mogollon C, van de Vegte-Bolmer M, van Gemert GJ, van Pul FJA, Ramesar J, Othman AS, et al.

Sci Rep, 2019 May 03;9(1):7061.
PMID: 31053746 DOI: 10.1038/s41598-019-43505-y

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Fulltext The Plasmodium falciparum male gametocyte protein P230p, a paralog of P230, is vital for ookinete formation and mosquito transmission

Marin-Mogollon C, van de Vegte-Bolmer M, van Gemert GJ, van Pul FJA, Ramesar J, Othman AS, et al.

Sci Rep, 2018 10 08;8(1):14902.
PMID: 30297725 DOI: 10.1038/s41598-018-33236-x

Two members of 6-cysteine (6-cys) protein family, P48/45 and P230, are important for gamete fertility in rodent and human malaria parasites and are leading transmission blocking vaccine antigens. Rodent and human parasites encode a paralog of P230, called P230p. While P230 is expressed in male and female parasites, P230p is expressed only in male gametocytes and gametes. In rodent malaria parasites this protein is dispensable throughout the complete life-cycle; however, its function in P. falciparum is unknown. Using CRISPR/Cas9 methodology we disrupted the gene encoding Pfp230p resulting in P. falciparum mutants (PfΔp230p) lacking P230p expression. The PfΔp230p mutants produced normal numbers of male and female gametocytes, which retained expression of P48/45 and P230. Upon activation male PfΔp230p gametocytes undergo exflagellation and form male gametes. However, male gametes are unable to attach to red blood cells resulting in the absence of characteristic exflagellation centres in vitro. In the absence of P230p, zygote formation as well as oocyst and sporozoite development were strongly reduced (>98%) in mosquitoes. These observations demonstrate that P230p, like P230 and P48/45, has a vital role in P. falciparum male fertility and zygote formation and warrants further investigation as a potential transmission blocking vaccine candidate.
Fulltext An Efficient 5G Data Plan Approach Based on Partially Distributed Mobility Architecture

Al Shinwan M, Abualigah L, Huy TD, Younes Shdefat A, Altalhi M, Kim C, et al.

Sensors (Basel), 2022 Jan 04;22(1).
PMID: 35009891 DOI: 10.3390/s22010349

Reaching a flat network is the main target of future evolved packet core for the 5G mobile networks. The current 4th generation core network is centralized architecture, including Serving Gateway and Packet-data-network Gateway; both act as mobility and IP anchors. However, this architecture suffers from non-optimal routing and intolerable latency due to many control messages. To overcome these challenges, we propose a partially distributed architecture for 5th generation networks, such that the control plane and data plane are fully decoupled. The proposed architecture is based on including a node Multi-session Gateway to merge the mobility and IP anchor gateway functionality. This work presented a control entity with the full implementation of the control plane to achieve an optimal flat network architecture. The impact of the proposed evolved packet Core structure in attachment, data delivery, and mobility procedures is validated through simulation. Several experiments were carried out by using NS-3 simulation to validate the results of the proposed architecture. The Numerical analysis is evaluated in terms of total transmission delay, inter and intra handover delay, queuing delay, and total attachment time. Simulation results show that the proposed architecture performance-enhanced end-to-end latency over the legacy architecture.
Fulltext Acceptability of multipurpose human papillomavirus vaccines among providers and mothers of adolescent girls: A mixed-methods study in five countries

Vielot NA, Goldberg SK, Zimet G, Smith SB, Anne McDonald M, Ramos S, et al.

Papillomavirus Res, 2017 Jun;3:126-133.
PMID: 28720446 DOI: 10.1016/j.pvr.2017.04.001

INTRODUCTION: Multipurpose vaccines (MPVs) could be formulated to prevent multiple sexually transmitted infections simultaneously. Little is known about acceptability of MPVs among vaccine health care providers (HCPs) or mothers of adolescent girls.
METHODS: 151 adolescent vaccine providers and 118 mothers of adolescent girls aged 9-14 were recruited from five geographically-diverse countries: Argentina, Malaysia, South Africa, South Korea, and Spain. We assessed providers' preferences for single-purpose human papillomavirus (HPV) vaccine versus MPVs (including HPV+herpes simplex virus (HSV)-2, HPV+HIV, or HPV+HSV-2+HIV) via quantitative surveys. Maternal MPV attitudes were assessed in four focus group discussions (FGDs) in each country.
RESULTS: Most providers preferred MPVs over single-purpose HPV vaccination, with preference ranging from 61% in Malaysia to 96% in South Africa. HPV+HSV-2+HIV was the most preferred MPV formulation (56-82%). Overall, 53% of the mothers preferred MPVs over single-purpose HPV vaccines, with strongest support in South Africa (90%) and lowest support in South Korea (29%). Convenience and trust in the health care system were commonly-cited reasons for MPV acceptability. Safety and efficacy concerns were common barriers to accepting MPVs, though specific concerns differed by country. Across FGDs, additional safety and efficacy information on MPVs were requested, particularly from trusted sources like HCPs.
CONCLUSIONS: Though maternal acceptability of MPVs varied by country, MPV acceptability would be enhanced by having HCPs provide parents with additional MPV vaccine safety and efficacy information. While most providers preferred MPVs, future health behavior research should identify acceptability barriers, and targeted provider interventions should equip providers to improve vaccination discussions with parents.
High-throughput manufacturing of epitaxial membranes from a single wafer by 2D materials-based layer transfer process

Kim H, Liu Y, Lu K, Chang CS, Sung D, Akl M, et al.

Nat Nanotechnol, 2023 May;18(5):464-470.
PMID: 36941360 DOI: 10.1038/s41565-023-01340-3

Layer transfer techniques have been extensively explored for semiconductor device fabrication as a path to reduce costs and to form heterogeneously integrated devices. These techniques entail isolating epitaxial layers from an expensive donor wafer to form freestanding membranes. However, current layer transfer processes are still low-throughput and too expensive to be commercially suitable. Here we report a high-throughput layer transfer technique that can produce multiple compound semiconductor membranes from a single wafer. We directly grow two-dimensional (2D) materials on III-N and III-V substrates using epitaxy tools, which enables a scheme comprised of multiple alternating layers of 2D materials and epilayers that can be formed by a single growth run. Each epilayer in the multistack structure is then harvested by layer-by-layer mechanical exfoliation, producing multiple freestanding membranes from a single wafer without involving time-consuming processes such as sacrificial layer etching or wafer polishing. Moreover, atomic-precision exfoliation at the 2D interface allows for the recycling of the wafers for subsequent membrane production, with the potential for greatly reducing the manufacturing cost.
Fulltext Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort

Erlandson KM, Geng LN, Selvaggi CA, Thaweethai T, Chen P, Erdmann NB, et al.

Ann Intern Med, 2024 Sep;177(9):1209-1221.
PMID: 39133923 DOI: 10.7326/M24-0737

BACKGROUND: There are currently no validated clinical biomarkers of postacute sequelae of SARS-CoV-2 infection (PASC).
OBJECTIVE: To investigate clinical laboratory markers of SARS-CoV-2 and PASC.
DESIGN: Propensity score-weighted linear regression models were fitted to evaluate differences in mean laboratory measures by prior infection and PASC index (≥12 vs. 0). (ClinicalTrials.gov: NCT05172024).
SETTING: 83 enrolling sites.
PARTICIPANTS: RECOVER-Adult cohort participants with or without SARS-CoV-2 infection with a study visit and laboratory measures 6 months after the index date (or at enrollment if >6 months after the index date). Participants were excluded if the 6-month visit occurred within 30 days of reinfection.
MEASUREMENTS: Participants completed questionnaires and standard clinical laboratory tests.
RESULTS: Among 10 094 participants, 8746 had prior SARS-CoV-2 infection, 1348 were uninfected, 1880 had a PASC index of 12 or higher, and 3351 had a PASC index of zero. After propensity score adjustment, participants with prior infection had a lower mean platelet count (265.9 × 109 cells/L [95% CI, 264.5 to 267.4 × 109 cells/L]) than participants without known prior infection (275.2 × 109 cells/L [CI, 268.5 to 282.0 × 109 cells/L]), as well as higher mean hemoglobin A1c (HbA1c) level (5.58% [CI, 5.56% to 5.60%] vs. 5.46% [CI, 5.40% to 5.51%]) and urinary albumin-creatinine ratio (81.9 mg/g [CI, 67.5 to 96.2 mg/g] vs. 43.0 mg/g [CI, 25.4 to 60.6 mg/g]), although differences were of modest clinical significance. The difference in HbA1c levels was attenuated after participants with preexisting diabetes were excluded. Among participants with prior infection, no meaningful differences in mean laboratory values were found between those with a PASC index of 12 or higher and those with a PASC index of zero.
LIMITATION: Whether differences in laboratory markers represent consequences of or risk factors for SARS-CoV-2 infection could not be determined.
CONCLUSION: Overall, no evidence was found that any of the 25 routine clinical laboratory values assessed in this study could serve as a clinically useful biomarker of PASC.
PRIMARY FUNDING SOURCE: National Institutes of Health.